Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01956435 · ClinicalTrials.gov registry record · NA
Excimer Light Treatment for Idiopathic Guttate Hypomelanosis: A Pilot Study
A NA study, sponsored by Seton Healthcare Family.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT01956435: Completed NA study, sponsored by Seton Healthcare Family.
NCT01956435 is a NA study that has completed, run by Seton Healthcare Family. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01956435, a NA study, has completed, sponsored by Seton Healthcare Family.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This pilot study will consist of 10 adult subjects with symmetric idiopathic guttate hypomelanosis on the lower legs. Subjects will be randomized to which extremity (right or left) will be treated. Treatments with the Xtrac Excimer laser will be performed twice weekly for 12 weeks using the typical vitiligo protocol. Our goal is to determine the effectiveness of excimer laser for repigmentation of idiopathic guttate hypomelanosis. Effectiveness will be graded by the blinded observer scale via photographic comparisons and will be graded by subject via survey every 4 weeks.
Primary Outcome
Effectiveness will be graded by the blinded observer scal via photographic comparisons at the end of the study. Efficacy was assessed by improvement from baseline using the following scale: -1 = Worsening of IGH; 0 = No Improvement (IGH remained stable); 1 = Mild improvement of IGH (some re-pigmentation on \<50% IGH); 2 = Moderate improvement (some re-pigmentation on \>50% or full re-pigmentation on \<75% IGH); 3 = Full re-pigmentation on \>75% IGH.
Interventions
- DEVICE Excimer Light Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-10 |
| Phase | NA |
What the finished NCT01956435 record still lists
NCT01956435 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Excimer Light Treatment is the first listed.
NCT01956435 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01956435 about?
NCT01956435 is a clinical study titled "Excimer Light Treatment for Idiopathic Guttate Hypomelanosis: A Pilot Study". This pilot study will consist of 10 adult subjects with symmetric idiopathic guttate hypomelanosis on the lower legs. Subjects will be randomized to which extremity (right or left) will be treated. Treatments with the Xtrac Excimer laser will be performed twice weekly for 12 weeks using the typical ...
What is the current status of trial NCT01956435?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2014-03. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01956435?
The interventions under investigation include: Excimer Light Treatment (DEVICE).
Who is sponsoring clinical trial NCT01956435?
This trial is sponsored by Seton Healthcare Family, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01956435's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia